326 related articles for article (PubMed ID: 19935145)
1. Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy.
Kao AW; Racine CA; Quitania LC; Kramer JH; Christine CW; Miller BL
Alzheimer Dis Assoc Disord; 2009; 23(4):365-70. PubMed ID: 19935145
[TBL] [Abstract][Full Text] [Related]
2. Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.
Gibbons CH; Levine T; Adler C; Bellaire B; Wang N; Stohl J; Agarwal P; Aldridge GM; Barboi A; Evidente VGH; Galasko D; Geschwind MD; Gonzalez-Duarte A; Gil R; Gudesblatt M; Isaacson SH; Kaufmann H; Khemani P; Kumar R; Lamotte G; Liu AJ; McFarland NR; Miglis M; Reynolds A; Sahagian GA; Saint-Hillaire MH; Schwartzbard JB; Singer W; Soileau MJ; Vernino S; Yerstein O; Freeman R
JAMA; 2024 Apr; 331(15):1298-1306. PubMed ID: 38506839
[TBL] [Abstract][Full Text] [Related]
3. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.
Claassen DO; Josephs KA; Ahlskog JE; Silber MH; Tippmann-Peikert M; Boeve BF
Neurology; 2010 Aug; 75(6):494-9. PubMed ID: 20668263
[TBL] [Abstract][Full Text] [Related]
4. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
[TBL] [Abstract][Full Text] [Related]
5. Impaired Sphingolipid Hydrolase Activities in Dementia with Lewy Bodies and Multiple System Atrophy.
Usenko TS; Senkevich KA; Bezrukova AI; Baydakova GV; Basharova KS; Zhuravlev AS; Gracheva EV; Kudrevatykh AV; Miliukhina IV; Krasakov IV; Khublarova LA; Fursova IV; Zakharov DV; Timofeeva AA; Irishina YA; Palchikova EI; Zalutskaya NM; Emelyanov AK; Zakharova EY; Pchelina SN
Mol Neurobiol; 2022 Apr; 59(4):2277-2287. PubMed ID: 35066761
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy.
Mori F; Piao YS; Hayashi S; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
J Neuropathol Exp Neurol; 2003 Aug; 62(8):812-9. PubMed ID: 14503637
[TBL] [Abstract][Full Text] [Related]
7. Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.
Foulds PG; Yokota O; Thurston A; Davidson Y; Ahmed Z; Holton J; Thompson JC; Akiyama H; Arai T; Hasegawa M; Gerhard A; Allsop D; Mann DM
Neurobiol Dis; 2012 Jan; 45(1):188-95. PubMed ID: 21856424
[TBL] [Abstract][Full Text] [Related]
8. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy Bodies.
Weintraub D; Irwin D
Continuum (Minneap Minn); 2022 Oct; 28(5):1314-1332. PubMed ID: 36222767
[TBL] [Abstract][Full Text] [Related]
10. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.
Boeve BF; Silber MH; Ferman TJ; Lucas JA; Parisi JE
Mov Disord; 2001 Jul; 16(4):622-30. PubMed ID: 11481685
[TBL] [Abstract][Full Text] [Related]
11. Depression in alpha-synucleinopathies: prevalence, pathophysiology and treatment.
Stefanova N; Seppi K; Scherfler C; Puschban Z; Wenning GK
J Neural Transm Suppl; 2000; (60):335-43. PubMed ID: 11205151
[TBL] [Abstract][Full Text] [Related]
12. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
[TBL] [Abstract][Full Text] [Related]
13. The mild cognitive impairment stage of dementia with Lewy bodies and Parkinson disease: a comparison of cognitive profiles.
Yoon JH; Lee JE; Yong SW; Moon SY; Lee PH
Alzheimer Dis Assoc Disord; 2014; 28(2):151-5. PubMed ID: 24126215
[TBL] [Abstract][Full Text] [Related]
14. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
Jellinger KA; Korczyn AD
BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
[TBL] [Abstract][Full Text] [Related]
15. Neuropathology and molecular diagnosis of Synucleinopathies.
Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
[TBL] [Abstract][Full Text] [Related]
16. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment in Parkinson's disease and dementia with Lewy bodies.
Aarsland D
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S144-8. PubMed ID: 26411499
[TBL] [Abstract][Full Text] [Related]
18. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
Jellinger KA
Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S
Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
[TBL] [Abstract][Full Text] [Related]
20. Predicting phenoconversion in pure autonomic failure.
Coon EA; Mandrekar JN; Berini SE; Benarroch EE; Sandroni P; Low PA; Singer W
Neurology; 2020 Aug; 95(7):e889-e897. PubMed ID: 32546656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
